EuroPCR 2023: Improving outcomes in mitral regurgitation
Francesco Maisano, Marianna Adamo, Alison Duncan, Georg Nickenig and Greg Stone discuss the role of COAPT trial evidence in reducing mitral regurgitation and securing optimal outcomes for patients. Points also discussed include patient selection, repair or replacement, and real-world registry evidence on reducing MR with TEER.
Related Videos
EuroPCR 2023: Defining the future
EuroPCR 2023: Tricuspid valve
EuroPCR 2023: Vascular access
EuroPCR 2023: COAPT 5-year follow-up
TAVI Summit - Cardiac imaging
SAFETY IS A JOURNEY | J. Van der Heyden & C. Besler
CardioMems™
T-TEER: Transcatheter Tricuspid Valve Repair - cases, tips, and tricks - 2025
ESC Tutorial 2024 E.Donal | Hands-on
AV VALVES 2023: Trending Topics – Timing
Cruz's testimonial
Navigating the Anatomy | Tricuspid focus